ISSN: 1352-0504
Journal Home
Journal Guideline
Journal of Viral Hepatitis Q1 Unclaimed
Journal of Viral Hepatitis is a journal indexed in SJR in Infectious Diseases and Virology with an H index of 110. It has a price of 3350 €. It has an SJR impact factor of 1,078 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,078.
Journal of Viral Hepatitis focuses its scope in these topics and keywords: hepatitis, chronic, virus, infection, men, treatment, patients, risk, psychosocial, therapy, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3350 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,078
SJR Impact factor110
H Index121
Total Docs (Last Year)509
Total Docs (3 years)4070
Total Refs1361
Total Cites (3 years)467
Citable Docs (3 years)2.52
Cites/Doc (2 years)33.64
Ref/DocOther journals with similar parameters
Nature Reviews Microbiology Q1
Clinical Microbiology Reviews Q1
The Lancet Infectious Diseases Q1
Cellular and Molecular Immunology Q1
Drug Resistance Updates Q1
Compare this journals
Aims and Scope
Best articles by citations
Hepatitis C antibody detection in dried blood spots
View moreRebuttal to letters by Buti and Esteban, and Jacobsen and McHutchison
View moreReversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C
View moreFas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection
View morePreoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma
View moreHealth care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population
View moreHigh hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy
View moreShould we test hepatitis C virus genotype and viraemia level in patients with chronic hepatitis C?
View moreInhibition of hepatitis B virus by retroviral vectors expressing antisense RNA
View moreImportance of age in chronic hepatitis C virus infection
View morePredicted secondary structure of the hepatitis G virus and GB virus-A 5' untranslated regions consistent with an internal ribosome entry site
View moreHuman leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial
View moreIncreased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis
View moreResponse to Article by Formann et al. (2003)
View moreRandomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C
View moreConsensus interferon: a novel interferon for the treatment of hepatitis C
View moreAn outbreak of enterically transmitted non-A, non-E viral hepatitis
View moreHepatitis C virus infection and related chronic liver disease in a resident elderly population: the Silea study
View moreExposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria
View moreProlonged therapy of chronic hepatitis C with ribavirin
View moreSecondary structure and hybridization accessibility of the hepatitis C virus negative strand RNA 5'-terminus
View moreEpidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland
View moreProlonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis
View moreImmunogenetics of hepatitis C virus
View more
Comments